Join

Compare · CNMD vs ZYXI

CNMD vs ZYXI

Side-by-side comparison of CONMED Corporation (CNMD) and Zynex Inc. (ZYXI): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CNMD and ZYXI operate in Biotechnology: Electromedical & Electrotherapeutic Apparatus (Health Care), so they compete in similar markets.
  • CNMD is the larger of the two at $1.16B, about 3.9x ZYXI ($296.3M).
  • Over the past year, CNMD is down 24.5% and ZYXI is down 94.1% - CNMD leads by 69.6 points.
  • CNMD has hit the wire 2 times in the past 4 weeks while ZYXI has been quiet.
  • CNMD has more recent analyst coverage (14 ratings vs 10 for ZYXI).
PerformanceCNMD-29.78%ZYXI-94.10%
2025-08-26+0.00%2026-04-24
MetricCNMDZYXI
Company
CONMED Corporation
Zynex Inc.
Price
$38.41+2.52%
$0.13-31.48%
Market cap
$1.16B
$296.3M
1M return
+3.74%
-77.93%
1Y return
-24.48%
-94.10%
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Exchange
NYSE
NASDAQ
IPO
1987
News (4w)
2
0
Recent ratings
14
10
CNMD

CONMED Corporation

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. It offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

ZYXI

Zynex Inc.

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. The company also supplies electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products; and distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers CM-1500, a blood volume monitor device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.

Latest CNMD

Latest ZYXI